Joint Conversations – August 2016
Global Cannabis News
SPECIAL ISSUE: The DEA Is Remains Publicly Ignorant
– The DEA Has Declined To Reclassify Marijuana –
The Drug Enforcement Administration continues to cling to an ignorant policy that has proven to be a failure since its conception. Marijuana will remain a Schedule l controlled substance, which declares it has “no currently accepted medical use and a high potential for abuse,” the Drug Enforcement Administration said Thursday. This keeps the drug in the same category as heroin, LSD and Ecstasy. The announcement is in response to two recent petitions asking the agency to reconsider this designation for the benefit of scientific research.
The decision is based on a “scientific and medical evaluation” conducted by the US Food and Drug Administration at the request of the DEA.”The DEA and the FDA continue to believe that scientifically valid and well-controlled clinical trials conducted under investigational new drug (IND) applications are the most appropriate way to conduct research on the medicinal uses of marijuana,” said a statement from the DEA.
Critics of the DEA have pointed out that marijuana researchers are caught in a Catch-22. In order to have more research, scientists need to do more studies. But in order to do that, their studies must be approved by federal agencies, including the DEA, the FDA and occasionally the National Institute on Drug Abuse, the largest public funder of marijuana research.The institute currently contracts with the University of Mississippi, which has held the sole license to grow research-grade marijuana in the entire country since 1968. Any US study that looks at marijuana needs to get its pot from the institute, whose mission isn’t to prove efficacy of the drug but rather its harm and abuse potential.
You can read the entire magazine below.